Ponte San Marco, Brescia (Italy), 27 July 2026 – The Cavagna Group announces the adoption of GasLive as the global brand for its Healthcare range, dedicated to solutions for respiratory therapy, oxygen therapy and sleep medicine.
Already part of the Cavagna Group’s brand portfolio following the acquisition of GasLive in 2024, the brand has now been chosen as the global identity for the Group’s Healthcare range. This decision highlights a brand that has built a solid reputation in the medical devices sector over time and which represents a comprehensive range of solutions for respiratory therapy, including oxygen concentrators, CPAP and BiPAP devices, sleep medicine systems and related accessories.
GasLive is now internationally recognised, with a particularly well-established presence in South American markets, where it has built up strong credibility over the years thanks to the quality of its solutions and its ability to meet the needs of a highly regulated sector.
With this decision, the Cavagna Group aims to strengthen the identity of its Healthcare division, presenting itself to the market with a single, recognisable brand capable of supporting the business’s international growth in a sector characterised by high technology and a strong focus on quality and innovation.
“We chose GasLive because it is a brand that has, over time, built up credibility and recognition within the healthcare sector. Bringing our range of respiratory therapy and sleep medicine products together under a single brand identity will enable us to present ourselves to international markets with an even clearer, more consistent and distinctive offering. This decision reflects our commitment to continuing to invest in innovation, quality and the development of solutions that are ever more closely aligned with the needs of patients and healthcare professionals.” explains Miriam Cavagna, Head of Marketing and Communications at Cavagna Group.
This transaction forms part of a medium- to long-term development strategy that the Cavagna Group intends to pursue in a structured manner, with the aim of consolidating its position in the medical sector and offering its network of customers and distributors a comprehensive and competitive portfolio of solutions.